MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with D

Dronedarone

Dronedarone 400mg tablets

Compatible

Stability notes for Dronedarone 400mg tablets

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Multaq 400mg tablets (Sanofi).

Suppliers (9) of Dronedarone 400mg tablets
Dronedarone 400mg tablets (A A H Pharmaceuticals Ltd)
Dronedarone 400mg tablets (Accord-UK Ltd)
Dronedarone 400mg tablets (Alliance Healthcare (Distribution) Ltd)
Dronedarone 400mg tablets (Aristo Pharma Ltd)
Dronedarone 400mg tablets (Milpharm Ltd)
Dronedarone 400mg tablets (Necessity Supplies Ltd)
Multaq 400mg tablets (Pharmaram Ltd)
Multaq 400mg tablets (Sanofi)
Multaq 400mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.